Capitalization 45.59B P/E ratio 2024 *
33.4x
P/E ratio 2025 * 22.5x
Enterprise value 52.53B EV / Sales 2024 *
3.37x
EV / Sales 2025 * 3.23x
Free-Float
99.72%
Yield 2024 *
3.4%
Yield 2025 * 3.51%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.42%
1 week+3.21%
Current month+3.71%
1 month+10.81%
3 months+13.13%
6 months+15.77%
Current year+10.45%
More quotes
1 week
22.04
Extreme 22.04
23.88
1 month
21.29
Extreme 21.29
23.88
Current year
17.67
Extreme 17.67
23.88
1 year
17.67
Extreme 17.67
23.88
3 years
17.67
Extreme 17.67
27.80
5 years
17.67
Extreme 17.67
27.80
10 years
17.67
Extreme 17.67
27.80
More quotes
Director TitleAgeSince
Chief Executive Officer - 2023-05-07
Director of Finance/CFO - 2023-04-30
Chief Tech/Sci/R&D Officer 52 2023-04-30
Manager TitleAgeSince
Director/Board Member - 2023-05-07
Chairman 68 2023-04-30
Director/Board Member 64 2023-05-03
More insiders
Name Weight AuM 1st Jan change Investor Rating
0.09% 38 M€ +24.94% -
0.07% 26 M€ +16.85% -
More ETFs: Kenvue Inc.
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.42%+3.21%+24.18% - 45.59B
-1.00%+0.58%+9.66%+13.41%391B
-0.76%-4.87%+13.88%+14.83%144B
-0.66%-1.76%+21.91%+17.91%75.13B
-1.18%-2.37%-1.20%+2.26%69.33B
-0.36%-2.71%+0.45%+30.59%29.71B
+1.08%-2.80%-43.71%-81.25%23.19B
-0.87%-2.86%+16.42%-0.27%19.11B
-3.66%-7.11%+19.05%+27.90%14.8B
-2.34%-4.55%-4.69%-15.26%10.98B
Average -0.66%-1.48%+5.59%+1.12% 82.32B
Weighted average by Cap. +0.10%-0.82%+9.70%+10.48%
See all sector performances
2024 *2025 *
Net sales 15.59B 16.1B
Net income 1.26B 2.03B
Net Debt 6.94B 6.36B
More financial data * Estimated data
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (41,8%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (29.9%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (28.3%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49.3%), Europe-Middle East-Africa (21.9%), Asia-Pacific (20.1%) and Latin America (8.7%).
Employees
22,000
More about the company
Date Price Change Volume
24-11-11 23.78 $ +0.42% 13,838,691
24-11-08 23.68 $ +3.09% 16,635,437
24-11-07 22.97 $ +2.09% 28,744,377
24-11-06 22.50 $ -3.14% 16,727,080
24-11-05 23.23 $ +0.82% 17,781,264

Delayed Quote Nyse, November 11, 2024 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
surperformance-ratings-light-chart KENVUE-INCMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
23.78USD
Average target price
24.27USD
Spread / Average Target
+2.07%
Consensus

Quarterly revenue - Rate of surprise